Changes in Immunoglobulin in Patients with Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies

被引：0
|
作者：
Vollmer, Brandi [1 ]
Bourassa, Timber [1 ]
Dao, Vi [1 ]
Sillau, Stefan [1 ]
Alvarez, Enrique [1 ]
Nair, Kavita [1 ,2 ]
机构：
[1] Univ Colorado, Dept Neurol, Aurora, CO USA
[2] Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P286/714
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [21] MONITORING OF IMMUNOGLOBULIN LEVELS IN RA PATIENTS ON ANTI CD20, RITUXIMAB
    Rice, Ceara
    Ghandi-Das, Dhivya
    Negi, Anurag
    RHEUMATOLOGY, 2020, 59 : 94 - 94
  • [22] Novel CD20 monoclonal antibodies for lymphoma therapy
    Cang, Shundong
    Mukhi, Nikhil
    Wang, Kemeng
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [23] Novel CD20 monoclonal antibodies for lymphoma therapy
    Shundong Cang
    Nikhil Mukhi
    Kemeng Wang
    Delong Liu
    Journal of Hematology & Oncology, 5
  • [24] Treatment of multiple sclerosis with Anti-CD20 antibodies
    Barun, Barbara
    Bar-Or, Amit
    CLINICAL IMMUNOLOGY, 2012, 142 (01) : 31 - 37
  • [25] Recurrent Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allografts Treated With Anti-CD20 Antibodies
    Buxeda, Anna
    Said, Samar M.
    Nasr, Samih H.
    Leung, Nelson
    El Ters, Mireille
    Cosio, Fernando G.
    TRANSPLANTATION, 2019, 103 (07) : 1477 - 1485
  • [26] Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
    Silvia R. Delgado
    Simon Faissner
    Ralf A. Linker
    Kottil Rammohan
    Journal of Neurology, 2024, 271 : 1515 - 1535
  • [27] Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
    Delgado, Silvia R.
    Faissner, Simon
    Linker, Ralf A.
    Rammohan, Kottil
    JOURNAL OF NEUROLOGY, 2024, 271 (04) : 1515 - 1535
  • [28] INFLUENCE OF HISTONE DEACETYLASE INHIBITORS (HDACI) ON CD20 EXPRESSION AND EFFICACY OF ANTI-CD20 MONOCLONAL ANTIBODIES
    Wanczyk, M.
    Kozikowski, M.
    Dwojak, M.
    Bojarczuk, K.
    Winiarska, M.
    HAEMATOLOGICA, 2013, 98 : 409 - 409
  • [29] Follow-up of a French cohort of progressive multiple sclerosis patients treated with anti-CD20 antibodies
    Einsiedler, M.
    Kremer, L.
    Fleury, M.
    Collongues, N.
    De Seze, J.
    Bigaut, K.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 211 - 211
  • [30] Influence of B Cell Depletion By Monoclonal Anti CD20 Antibodies in Systemic Sclerosis: Results of a Randomized Placebo Controlled Trial
    Ben Said-Bouyeri, Samira
    Meijs, Jessica
    Marsan, Nina Ajmone
    Schouffoer, Anne A.
    Ninaber, Maarten K.
    Scherer, Hans Ulrich
    Bonte-Mineur, Femke
    Huizinga, T. W. J.
    de Vries-Bouwstra, Jeska K.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345